Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrustpilot Regulatory News (TRST)

Share Price Information for Trustpilot (TRST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    4.20 (1.68%)
Bid:
256.20
Ask:
256.80
Spread: 0.60 (0.234%)
Market Cap: £982.28m
TRST Live PriceLast checked at - London Stock Exchange

Intraday Trustpilot Share Chart

Trading Statement

13 Jul 2023 07:00

RNS Number : 9142F
Trustpilot Group PLC
13 July 2023
 

Trustpilot Group plc

13 July 2023

 

Trading update for the half-year ended 30 June 2023

 

Group revenue increased 18% with H1 adj. EBITDA of approximately $3m - upgrading profitability guidance for FY23

 

Trustpilot Group plc ("Trustpilot"), a leading global review platform, provides an update on trading for the six months ended 30 June 2023 ("H1'23").

 

US$

H1'23

H1'22

YoY actual

%

YoY constant currency %

Total revenue

$85m

$73m

+15

+18

ARR1

$180m

$149m

+21

+17

Total bookings2

$98m

$87m

+13

+16

 

H1'23 financial highlights

Trustpilot expects to report Group revenue of $85m (H1'22: $73m), up 18%3 at constant currency, with adj. EBITDA of approximately $3m (H1'22: $(5.4)m). We expect total annual recurring revenue (ARR) of $180m (H1'22: $149m), up 17%, with total bookings up 16% to $98m (H1'22: $87m). The last twelve months ("LTM") net dollar retention rate was 99% in the period (H1'22: 100%).

 

Regionally, bookings growth was 15% in the UK and 21% in Europe & RoW, a resilient performance against a challenging macroeconomic backdrop. In North America, bookings increased 11%, with an acceleration in Q2 aided by an encouraging improvement in our US net dollar retention rate, and continuing benefits from our refreshed go-to-market strategy in the region.

 

Our balance sheet remains strong and our net cash balance increased to $83m at the end of H1, reflecting positive free cash flow in the period, compared to $73.5m on 31 December 2022.

 

Update on appointment of new Chief Executive Officer

We are pleased with the progress being made in the search for a new Chief Executive Officer and look forward to updating the market in due course.

 

Outlook

We reiterate our expectation for FY'23 of mid-teens cc revenue growth. Due to resilient trading combined with improved operational efficiency, we now expect like-for-like full-year adj. EBITDA4 above the top end of the range of market expectations5 (excluding the effects of IFRS 15 - see note 6 below).

 

Notice of half-year results

Trustpilot is scheduled to report interim results for the six months ended 30 June 2023 on Tuesday 19 September 2023. On that day, a webcast and conference call for analysts and investors will take place at 09:00 BST. For registration and access to the webcast please visit https://investors.trustpilot.com.

 

 

Enquiries

Trustpilot

Derek Brown, Head of Investor Relations

Peter Holten Mühlmann, CEO

Hanno Damm, CFO

 

investor.relations@trustpilot.com

https://investors.trustpilot.com

 

Financial PR

Teneo

James Macey White

Ed Cropley

+44 20 7353 4200

 

About Trustpilot

Trustpilot was founded in 2007 with a vision to create an independent currency of trust. A digital platform that brings businesses and consumers together to foster trust and inspire collaboration. We are free to use, open to everybody and built on transparency.

 

Trustpilot hosts reviews to help consumers shop with confidence and deliver rich insights to help businesses improve the experience they offer. The more consumers use our platform and share their own opinions; the richer the insights we offer businesses; and the more opportunities they have to earn the trust of consumers, from all around the world.

 

Trustpilot has over 850 employees and is headquartered in Copenhagen, with operations in London, Edinburgh, New York, Denver, Melbourne, Berlin, Amsterdam, and Milan.

 

1 Annual Recurring Revenue = Monthly Recurring Revenue x 12

2 The annual contract value of contracts signed in a given period

3 All YoY growth rates are shown on a constant currency basis

4 Adjusted EBITDA is defined as earnings before interest, tax, depreciation and amortisation, adjusted to exclude share-based compensation and restructuring costs

5 The current analyst consensus range for adjusted EBITDA of $2.4m to 4.0m (with a mean of $2.9m), based on company-compiled consensus representing the aggregate forecasts of 8 analysts collated on 28 April 2023

6 As our business expands and becomes profitable, under IFRS 15 - "Revenue from Contracts with Customers" - the Group is required to assess the recoverability of the incremental costs of obtaining a contract. Incremental costs for the Group relate largely to sales commissions paid to employees on new business. The Group has performed an assessment of recoverability and where costs are recoverable the Group intends to capitalise these commissions in H1'23 and to amortise them over the customer's expected useful life.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGMNZFFGFZG
Date   Source Headline
11th Jan 20247:00 amRNSShare Buyback Programme
11th Jan 20247:00 amRNSTrading update for the year ended 31 December 2023
2nd Jan 20247:00 amRNSBlock listing Interim Review
29th Dec 20231:27 pmRNSTotal Voting Rights
30th Nov 20232:28 pmRNSTotal Voting Rights
17th Nov 20237:00 amRNSBlock Listing Application
31st Oct 20232:04 pmRNSTotal Voting Rights
13th Oct 202311:17 amRNSTR-1 - Notification of major holdings
13th Oct 20239:38 amRNSBoard Committee Membership Changes
11th Oct 20237:00 amRNSResult of secondary placing in Trustpilot
10th Oct 20234:49 pmRNSProposed secondary placing in Trustpilot Group PLC
3rd Oct 20237:00 amRNSTrustpilot launches Reviews for Salesforce
27th Sep 202312:00 pmRNSDirector/PDMR Shareholding
25th Sep 202310:00 amRNSTR-1 - Notification of major holdings
21st Sep 202312:00 pmRNSDirector/PDMR Shareholding
21st Sep 202312:00 pmRNSPDMR notification - grant of LTIP award
19th Sep 20237:00 amRNSResults for the six months ended 30 June 2023
13th Sep 20234:01 pmRNSDirectorate Change
31st Aug 20232:18 pmRNSTotal Voting Rights
31st Jul 20233:00 pmRNSTotal Voting Rights
17th Jul 20237:00 amRNSAppointment of Chief Executive Officer
13th Jul 20237:00 amRNSTrading Statement
3rd Jul 20233:50 pmRNSTR-1 - Notification of major holdings
3rd Jul 20237:00 amRNSBlock listing Interim Review
30th Jun 20233:26 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20231:58 pmRNSTotal Voting Rights
23rd May 20235:14 pmRNSResult of AGM
28th Apr 20232:45 pmRNSTotal Voting Rights
19th Apr 20235:04 pmRNSAnnual Financial Report
11th Apr 202312:13 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:11 pmRNSDirector/PDMR Shareholding
31st Mar 20233:42 pmRNSTotal Voting Rights
30th Mar 20234:13 pmRNSDirector Declaration
28th Mar 20237:00 amRNSPDMR notification - grant of LTIP awards
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
21st Mar 20237:00 amRNSResults for the year ended 31 December 2022
21st Mar 20237:00 amRNSUpdate regarding management transition
13th Mar 20237:00 amRNSUpdate regarding liquidity position and resilience
28th Feb 20232:30 pmRNSTotal Voting Rights
24th Feb 20237:00 amRNSChair Succession
13th Feb 20239:20 amRNSTR-1 - Notification of major holdings
8th Feb 202311:52 amRNSTR-1 - Notification of major holdings
31st Jan 20232:25 pmRNSTotal Voting Rights
20th Jan 20237:00 amRNSTR-1 - Notification of major holdings
12th Jan 20237:00 amRNSTrading update for the year to 31 Dec 2022
10th Jan 20237:00 amRNSBlock Listing Application
3rd Jan 20237:00 amRNSBlock listing Interim Review
30th Dec 20221:00 pmRNSTotal Voting Rights
1st Dec 20222:04 pmRNSBoard Committee Membership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.